CAS: 1326232-46-5 - Anifrolumab
Formel:Unspecified
- Synonyme:
- Immunoglobulin G1, anti-(human type I interferon receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546 κ-chain, dimer
- MEDI 546
- Anifrolumab
- Immunoglobulin G1, anti-(human interferon α/β receptor) (human monoclonal MEDI-546 heavy chain), disulfide with human monoclonal MEDI-546 κ-chain, dimer
- Anifrolumab-fnia
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | Anifrolumab REF: TM-T77432CAS: 1326232-46-5 | 95% - SDS-PAGE:95% SEC-HPLC:95% | 183,00 €~1.810,00 € | Do 24 Okt 24 |
 | Anifrolumab REF: 3D-CLA1340CAS: 1326232-46-5 | - - - | Nachfragen | Di 05 Nov 24 |
Anifrolumab
CAS:1326232-46-5
Anifrolumab(MEDI-546) is a potent type I interferon (IFN) receptor antagonist, a human monoclonal antibody that …
Reinheit:
95% - SDS-PAGE:95% SEC-HPLC:95%
Farbe und Form:
Solid
Ref: TM-T77432
| 1mg | 183,00 € | ||
| 5mg | 416,00 € | ||
| 10mg | 641,00 € | ||
| 25mg | 1.000,00 € | ||
| 50mg | 1.355,00 € | ||
| 100mg | 1.810,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 24. Oktober 2024
Anifrolumab
CAS:1326232-46-5
Monoclonal antibody targeting Interferon α/β receptor; used to treat systemic lupus erythematosus
Ref: 3D-CLA1340
| Unbestimmte Größe | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 5. November 2024
